ID GRM1_MOUSE Reviewed; 1199 AA. AC P97772; Q6AXG4; Q9EPV6; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 11-APR-2003, sequence version 2. DT 27-MAR-2024, entry version 204. DE RecName: Full=Metabotropic glutamate receptor 1; DE Short=mGluR1; DE Flags: Precursor; GN Name=Grm1; Synonyms=Gprc1a, Mglur1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3). RC STRAIN=ICR; TISSUE=Brain; RX PubMed=10581402; DOI=10.1016/s0169-328x(99)00239-9; RA Zhu H., Ryan K., Chen S.; RT "Cloning of novel splice variants of mouse mGluR1."; RL Brain Res. Mol. Brain Res. 73:93-103(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 945-1127 (ISOFORM 1). RC STRAIN=C57BL/6J; RA Watanabe M.; RL Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200; RA Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.; RT "Comprehensive identification of phosphorylation sites in postsynaptic RT density preparations."; RL Mol. Cell. Proteomics 5:914-922(2006). RN [5] RP TISSUE SPECIFICITY. RX PubMed=17296554; DOI=10.1016/j.neuron.2007.01.019; RA Ihara M., Yamasaki N., Hagiwara A., Tanigaki A., Kitano A., Hikawa R., RA Tomimoto H., Noda M., Takanashi M., Mori H., Hattori N., Miyakawa T., RA Kinoshita M.; RT "Sept4, a component of presynaptic scaffold and Lewy bodies, is required RT for the suppression of alpha-synuclein neurotoxicity."; RL Neuron 53:519-533(2007). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-853; THR-871; SER-969; RP SER-1097; SER-1147 AND SER-1154, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP FUNCTION, AND MUTAGENESIS OF ILE-536. RX PubMed=26427409; DOI=10.1007/978-3-319-17121-0_24; RA Charette J.R., Samuels I.S., Yu M., Stone L., Hicks W., Shi L.Y., RA Krebs M.P., Naggert J.K., Nishina P.M., Peachey N.S.; RT "A Chemical Mutagenesis Screen Identifies Mouse Models with ERG Defects."; RL Adv. Exp. Med. Biol. 854:177-183(2016). CC -!- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding CC causes a conformation change that triggers signaling via guanine CC nucleotide-binding proteins (G proteins) and modulates the activity of CC down-stream effectors. Signaling activates a phosphatidylinositol- CC calcium second messenger system. May participate in the central action CC of glutamate in the CNS, such as long-term potentiation in the CC hippocampus and long-term depression in the cerebellum (By. CC similarity). May function in the light response in the retina CC (PubMed:26427409). {ECO:0000269|PubMed:26427409}. CC -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). The PPXXF motif CC binds HOMER1, HOMER2 and HOMER3. Interacts with TAMALIN (By CC similarity). Interacts with RYR1, RYR2, ITPR1, SHANK1 and SHANK3. CC Interacts with SHIA1 (By similarity). {ECO:0000250|UniProtKB:P23385}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q13255}; CC Multi-pass membrane protein {ECO:0000250|UniProtKB:Q13255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; Synonyms=A; CC IsoId=P97772-1; Sequence=Displayed; CC Name=2; Synonyms=B; CC IsoId=P97772-2; Sequence=VSP_007186, VSP_007187; CC Name=3; Synonyms=E55; CC IsoId=P97772-3; Sequence=VSP_007184, VSP_007185; CC -!- TISSUE SPECIFICITY: Expressed in the striatum (at protein level). CC {ECO:0000269|PubMed:17296554}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF320126; AAG41991.2; -; mRNA. DR EMBL; BC067057; AAH67057.1; -; mRNA. DR EMBL; BC079566; AAH79566.1; -; mRNA. DR EMBL; U89891; AAB48099.1; -; mRNA. DR CCDS; CCDS23696.1; -. [P97772-1] DR CCDS; CCDS48499.1; -. [P97772-2] DR RefSeq; NP_001107805.1; NM_001114333.2. [P97772-2] DR RefSeq; NP_058672.1; NM_016976.3. [P97772-1] DR RefSeq; XP_006512612.1; XM_006512549.3. [P97772-1] DR AlphaFoldDB; P97772; -. DR SMR; P97772; -. DR BioGRID; 200073; 11. DR CORUM; P97772; -. DR IntAct; P97772; 7. DR MINT; P97772; -. DR STRING; 10090.ENSMUSP00000037255; -. DR BindingDB; P97772; -. DR ChEMBL; CHEMBL2892; -. DR GlyCosmos; P97772; 5 sites, No reported glycans. DR GlyGen; P97772; 6 sites, 1 O-linked glycan (1 site). DR iPTMnet; P97772; -. DR PhosphoSitePlus; P97772; -. DR SwissPalm; P97772; -. DR jPOST; P97772; -. DR MaxQB; P97772; -. DR PaxDb; 10090-ENSMUSP00000037255; -. DR PeptideAtlas; P97772; -. DR ProteomicsDB; 269836; -. [P97772-1] DR ProteomicsDB; 269837; -. [P97772-2] DR ProteomicsDB; 269838; -. [P97772-3] DR Pumba; P97772; -. DR Antibodypedia; 2943; 814 antibodies from 43 providers. DR DNASU; 14816; -. DR Ensembl; ENSMUST00000044306.13; ENSMUSP00000037255.7; ENSMUSG00000019828.14. [P97772-1] DR Ensembl; ENSMUST00000105560.2; ENSMUSP00000101189.2; ENSMUSG00000019828.14. [P97772-2] DR Ensembl; ENSMUST00000105561.9; ENSMUSP00000101190.3; ENSMUSG00000019828.14. [P97772-2] DR GeneID; 14816; -. DR KEGG; mmu:14816; -. DR UCSC; uc007ejh.2; mouse. [P97772-2] DR UCSC; uc007eji.2; mouse. [P97772-1] DR AGR; MGI:1351338; -. DR CTD; 2911; -. DR MGI; MGI:1351338; Grm1. DR VEuPathDB; HostDB:ENSMUSG00000019828; -. DR eggNOG; KOG1056; Eukaryota. DR GeneTree; ENSGT01030000234595; -. DR HOGENOM; CLU_005389_0_1_1; -. DR InParanoid; P97772; -. DR OMA; NEMACNQ; -. DR OrthoDB; 5388627at2759; -. DR PhylomeDB; P97772; -. DR TreeFam; TF313240; -. DR Reactome; R-MMU-416476; G alpha (q) signalling events. DR Reactome; R-MMU-420499; Class C/3 (Metabotropic glutamate/pheromone receptors). DR Reactome; R-MMU-6794361; Neurexins and neuroligins. DR BioGRID-ORCS; 14816; 3 hits in 76 CRISPR screens. DR ChiTaRS; Grm1; mouse. DR PRO; PR:P97772; -. DR Proteomes; UP000000589; Chromosome 10. DR RNAct; P97772; Protein. DR Bgee; ENSMUSG00000019828; Expressed in medial dorsal nucleus of thalamus and 82 other cell types or tissues. DR GO; GO:0030424; C:axon; ISO:MGI. DR GO; GO:0030425; C:dendrite; IDA:UniProtKB. DR GO; GO:0043197; C:dendritic spine; ISO:MGI. DR GO; GO:0038037; C:G protein-coupled receptor dimeric complex; ISO:MGI. DR GO; GO:0038038; C:G protein-coupled receptor homodimeric complex; ISO:MGI. DR GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO. DR GO; GO:0043005; C:neuron projection; IDA:BHF-UCL. DR GO; GO:0043025; C:neuronal cell body; TAS:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0014069; C:postsynaptic density; IDA:MGI. DR GO; GO:0098839; C:postsynaptic density membrane; ISO:MGI. DR GO; GO:0045211; C:postsynaptic membrane; ISO:MGI. DR GO; GO:0042734; C:presynaptic membrane; ISO:MGI. DR GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO. DR GO; GO:0001640; F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; IBA:GO_Central. DR GO; GO:0098872; F:G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; IDA:SynGO. DR GO; GO:0099530; F:G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential; ISO:MGI. DR GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB. DR GO; GO:0099583; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; IMP:SynGO. DR GO; GO:0030331; F:nuclear estrogen receptor binding; ISO:MGI. DR GO; GO:0001639; F:PLC activating G protein-coupled glutamate receptor activity; TAS:MGI. DR GO; GO:0019722; P:calcium-mediated signaling; ISO:MGI. DR GO; GO:0071257; P:cellular response to electrical stimulus; IMP:MGI. DR GO; GO:0007216; P:G protein-coupled glutamate receptor signaling pathway; ISO:MGI. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:MGI. DR GO; GO:0098712; P:L-glutamate import across plasma membrane; IDA:MGI. DR GO; GO:0007626; P:locomotory behavior; IMP:UniProtKB. DR GO; GO:0007206; P:phospholipase C-activating G protein-coupled glutamate receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB. DR GO; GO:0051930; P:regulation of sensory perception of pain; IDA:UniProtKB. DR GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISO:MGI. DR GO; GO:0019233; P:sensory perception of pain; IMP:UniProtKB. DR CDD; cd15449; 7tmC_mGluR1; 1. DR CDD; cd06374; PBP1_mGluR_groupI; 1. DR Gene3D; 3.40.50.2300; -; 2. DR Gene3D; 2.10.50.30; GPCR, family 3, nine cysteines domain; 1. DR InterPro; IPR001828; ANF_lig-bd_rcpt. DR InterPro; IPR000337; GPCR_3. DR InterPro; IPR011500; GPCR_3_9-Cys_dom. DR InterPro; IPR038550; GPCR_3_9-Cys_sf. DR InterPro; IPR017978; GPCR_3_C. DR InterPro; IPR017979; GPCR_3_CS. DR InterPro; IPR001256; GPCR_3_mGluR1. DR InterPro; IPR000162; GPCR_3_mtglu_rcpt. DR InterPro; IPR019588; Metabotropic_Glu_rcpt_Homer-bd. DR InterPro; IPR028082; Peripla_BP_I. DR PANTHER; PTHR24060; METABOTROPIC GLUTAMATE RECEPTOR; 1. DR PANTHER; PTHR24060:SF29; METABOTROPIC GLUTAMATE RECEPTOR 1; 1. DR Pfam; PF00003; 7tm_3; 1. DR Pfam; PF01094; ANF_receptor; 1. DR Pfam; PF10606; GluR_Homer-bdg; 1. DR Pfam; PF07562; NCD3G; 1. DR PRINTS; PR00248; GPCRMGR. DR PRINTS; PR01051; MTABOTROPC1R. DR PRINTS; PR00593; MTABOTROPICR. DR SMART; SM01229; GluR_Homer-bdg; 1. DR SUPFAM; SSF53822; Periplasmic binding protein-like I; 1. DR PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1. DR PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1. DR PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1. DR PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1. DR Genevisible; P97772; MM. PE 1: Evidence at protein level; KW Alternative splicing; Cell membrane; Disulfide bond; KW G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein; KW Receptor; Reference proteome; Signal; Transducer; Transmembrane; KW Transmembrane helix. FT SIGNAL 1..20 FT /evidence="ECO:0000255" FT CHAIN 21..1199 FT /note="Metabotropic glutamate receptor 1" FT /id="PRO_0000012923" FT TOPO_DOM 21..592 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 593..615 FT /note="Helical; Name=1" FT /evidence="ECO:0000250" FT TOPO_DOM 616..629 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 630..650 FT /note="Helical; Name=2" FT /evidence="ECO:0000250" FT TOPO_DOM 651..658 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 659..680 FT /note="Helical; Name=3" FT /evidence="ECO:0000250" FT TOPO_DOM 681..703 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 704..727 FT /note="Helical; Name=4" FT /evidence="ECO:0000250" FT TOPO_DOM 728..750 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 751..772 FT /note="Helical; Name=5" FT /evidence="ECO:0000250" FT TOPO_DOM 773..785 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 786..807 FT /note="Helical; Name=6" FT /evidence="ECO:0000250" FT TOPO_DOM 808..815 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 816..840 FT /note="Helical; Name=7" FT /evidence="ECO:0000250" FT TOPO_DOM 841..1199 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT REGION 882..906 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 959..1035 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1055..1082 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1117..1177 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 959..973 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1011..1033 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1068..1082 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1157..1177 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 74 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT BINDING 165 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT BINDING 186..188 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT BINDING 236 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT BINDING 318 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT BINDING 409 FT /ligand="L-glutamate" FT /ligand_id="ChEBI:CHEBI:29985" FT /evidence="ECO:0000250" FT MOD_RES 853 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 871 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 894 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P23385" FT MOD_RES 969 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1097 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1147 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1151 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P23385" FT MOD_RES 1154 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT CARBOHYD 98 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 223 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 397 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 515 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 747 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 67..109 FT /evidence="ECO:0000250" FT DISULFID 140 FT /note="Interchain" FT /evidence="ECO:0000250" FT DISULFID 289..291 FT /evidence="ECO:0000250" FT DISULFID 378..394 FT /evidence="ECO:0000250" FT DISULFID 432..439 FT /evidence="ECO:0000250" FT DISULFID 657..746 FT /evidence="ECO:0000250" FT VAR_SEQ 317..321 FT /note="SDGWA -> RDSRN (in isoform 3)" FT /evidence="ECO:0000303|PubMed:10581402" FT /id="VSP_007184" FT VAR_SEQ 322..1199 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:10581402" FT /id="VSP_007185" FT VAR_SEQ 887..906 FT /note="NSNGKSVSWSEPGGRQAPKG -> KKRQPEFSPSSQCPSAHVQL (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:10581402, FT ECO:0000303|PubMed:15489334" FT /id="VSP_007186" FT VAR_SEQ 907..1199 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:10581402, FT ECO:0000303|PubMed:15489334" FT /id="VSP_007187" FT MUTAGEN 536 FT /note="I->K: Normal response to light but reduced retinal FT electrical activity in response to light in dark adapted FT retinas. Gross morphology is normal." FT /evidence="ECO:0000269|PubMed:26427409" SQ SEQUENCE 1199 AA; 133212 MW; FE5370AF160CC16E CRC64; MVRLLLIFFP MIFLEMSILP RMPDRKVLLA GASSQRSVAR MDGDVIIGAL FSVHHQPPAE KVPERKCGEI REQYGIQRVE AMFHTLDKIN ADPVLLPNIT LGSEIRDSCW HSSVALEQSI EFIRDSLISI RDEKDGLNRC LPDGQTLPPG RTKKPIAGVI GPGSSSVAIQ VQNLLQLFDI PQIAYSATSI DLSDKTLYKY FLRVVPSDTL QARAMLDIVK RYNWTYVSAV HTEGNYGESG MDAFKELAAQ EGLCIAHSDK IYSNAGEKSF DRLLRKLRER LPKARVVVCF CEGMTVRGLL SAMRRLGVVG EFSLIGSDGW ADRDEVIEGY EVEANGGITI KLQSPEVRSF DDYFLKLRLD TNTRNPWFPE FWQHRFQCRL PGHLLENPNF KKVCTGNESL EENYVQDSKM GFVINAIYAM AHGLQNMHHA LCPGYVGLCD AMKPIDGRKL LDFLIKSSFV GVSGEEVWFD EKGDAPGRYD IMNLQYTEAN RYDYVHVGTW HEGVLNIDDY KIQMNKSGMV RSVCSEPCLK GQIKVIRKGE VSCCWICTAC KENEFVQDEF TCRACDLGWW PNAELTGCEP ITIRYLEWSD IESIIAIAFS CLGILVTLFV TLIFVLYRDT PVVKSSSREL CYIILAGIFL GYVCPFTLIA KPTTTSCYLQ RLLVGLSSAM CYSALVTKTN RIARILAGSK KKICTRKPRF MSAWAQVIIA SILISVQLTL VVTLIIMEPP MPILSYPSIK EVYLICNTSN LGVVAPVGYN GLLIMSCTYY AFKTRNVPAN FNEAKYIAFT MYTTCIIWLA FVPIYFGSNY KIITTCFAVS LSVTVALGCM FTPKMYIIIA KPERNVRSAF TTSDVVRMHV GDGKLPCRSN TFLNIFRRKK PGAGNANSNG KSVSWSEPGG RQAPKGQHVW QRLSVHVKTN ETACNQTAVI KPLTKSYQGS GKSLTFSDAS TKTLYNVEEE DNTPSTHFSP PSSPSMVVHR RGPPVATTPP LPPHLSAEET PLFLADSVIP KGLPPPLPQQ QQQPPPQPPP QQPKSLMDQL QGVVTNFGSG IPDFHAVLAG PGTPGNGLRS LYPPPPPPQH LQMLPLQLST FREEPISPPG EDDDDDSSER FKLLQEFVYE REGNTEEDDL EEEEDLPAAS KLTPEDSPAL TPPSPFRDSV ASGSSVPSSP VSESVLCTPP NVTYASVILR DYKQSSSTL //